All right. I hope everybody can hear me. Welcome, everyone, to this fireside chat for Getinge. I'm Aisyah Noor, Head of European MedTech Research at Morgan Stanley. It's my pleasure to host Getinge's ...
Getinge will issue its Q2 Report 2026 on July 17, 2026, at 08.00 a.m. CEST, followed by a conference call at 10.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO. Fund ...
GOTHENBURG, Sweden, June 2, 2026 /PRNewswire/ --Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and ...
GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and ...
Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency ...
GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- "We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the ...
“We often hear from clinicians: ‘It would be great if the systems worked together—regardless of who made them,’” said Brian Bell, Philips’ business leader for enterprise hospital monitoring.
Born July 2, 1954 in Chambersburg, PA he was a son of the late Wayne W. and Shirley A. (Maun) Bard. Mike was a 1972 graduate of James Buchanan High School, Mercersburg, PA. He worked in ...
Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc. The total market for transplants has been growing rapidly in recent years and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results